This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...
In contrast, Covid-19 is an infectious disease caused by the SARS-CoV-2 virus, which is part of the Coronaviridae family, as ...
As for GBS itself, this neurological ailment can be severe, attacking nerves and warranting hospitalisation for weeks or ...
On Tuesday, January 7, the FDA announced it would now be requiring GSK and Pfizer’s RSV vaccines to hold warnings of a risk ...
U.S. approved the RSVpreF vaccine for adults 60 years and older in 2023, recommending it only based on individual’s decisions ...
Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...
Regulators say, however, the benefits of vaccination with Abrysvo and Arexvy in preventing respiratory syncytial virus ...
The best way to protect yourself from the flu and COVID is to get vaccinated. This can reduce your chances of getting sick ...
Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.
The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback